Asia Pacific Intraoperative Neuromonitoring Market Growth Opportunities and Forecast by 2027

The Asia Pacific intraoperative neuromonitoring market is expected to reach US$ 915.59 million by 2027 from US$ 491.50 million in 2019; it is estimated to grow at a CAGR of 8.2% from 2020 to 2027.

Factors such as rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring are expected to propel the growth of the market. However, lack of skilled professionals is the major factor hindering the market growth.

Intraoperative neurophysiological monitoring (IOM) is an integral part of most of the surgical procedures. It has been widely used to prevent the neurological damage caused during number of surgeries, identify neural structures and thereby prevent post-operative impairments. IOM employs a wide range of modalities, which includes motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).

The growing prevalence of neurological disorders and increasing emphasis on patient safety during complicated surgeries are driving the growth of the intraoperative neuromonitoring market. Neurological diseases encompass the brain, spine, and the nerve disorders. The neurovascular systems are dependent on the continuous supply of oxygen and nutrients. The supply of oxygen and nutrients to the brain is essential for its working. Therefore, a defect in the system can impair the function and become a life-threatening factor. Neurological complications include stroke and spinal cord ischemia. During recent years, the prevalence of neurological disorders has increased significantly. For instance, the cerebral aneurysm is one of the neurovascular diseases that is rising significantly.

Moreover, traumatic brain injuries have also increased, leading to brain-related fatalities. For instance, Traumatic brain injury (TBI) is a major cause of mortality and morbidity. China has more patients with traumatic brain injury (TBI) than most other countries in the world, making this condition a major public health concern. Population-based mortality of TBI in China is estimated to be approximately 13 cases per 100 000 people, which is similar to the rates reported in other countries. Intraoperative neuromonitoring (IONM) is the only option to assess the early symptoms and conditions during emergency brain trauma. These benefits have made it mandatory in neurosurgeries. Rising prevalence of neurological diseases is anticipated to drive the need for the IONM, in turn, increasing demand for IONM products.

Asia Pacific countries are expecting to witness a huge challenge due to growing COVID-19. The pandemic could affect three main aspects of the global economy: production, supply chain, and firms and financial markets. However, coherent, coordinated, and credible policy responses are expected to offer the best chance at limiting the economic fallout. This pandemic is affecting the business operation of the various key players operating in this region.

Rest of Asia Pacific Intraoperative neuromonitoring Market, Revenue and Forecast to 2027 (US$ Mn)

ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION

By Product

• Systems
• Accessories
• Services

By Source

• Insourced Monitoring
• Outsourced Monitoring

By Modality

• Motor Evoked Potentials
• Somatosensory Evoked Potentials
• Electroencephalography
• Electromyography
• Brainstem Auditory Evoked Potentials
• Visual Evoked Potentials

By Application

• Spinal Surgery
• Neurosurgery
• Vascular Surgery
• ENT Surgery
• Orthopedic Surgery
• Other Surgeries

By End User

• Hospitals
• Ambulatory Surgical Centers

By Country

• Japan
• China
• India
• South Korea
• Australia

Company Profiles

• Medtronic
• Nihon Kohden Corporation
• Natus Medical Incorporated
• NuVasive, Inc
• SpecialtyCare

Asia Pacific Intraoperative Neuromonitoring Report Scope